Exosens Reports Q3 Revenue Growth, Confirms 2026 Guidance

Exosens reported a 23.5% increase in revenue for the third quarter of 2026, contributing to a total revenue of 386.9 million euros for the first nine months of the year, an 18% year-on-year rise. The company confirmed its full-year 2026 financial guidance, projecting revenue growth of approximately 20% within a range of 558 million to 570 million euros and an adjusted EBITDA between 186 million and 192 million euros. Management attributed the quarterly growth to robust demand and a faster-than-anticipated ramp-up of production capacity.

While the adjusted gross margin reached 194.9 million euros over the nine-month period, the margin rate decreased by 85 basis points to 50.4%, which the company linked to a shift in product mix and increased personnel costs associated with the deployment of a new manufacturing facility in the United States.